349 related articles for article (PubMed ID: 20655547)
1. Elevated plasma levels of tissue inhibitors of metalloproteinase-1 and their overexpression in muscle in human and mouse muscular dystrophy.
Sun G; Haginoya K; Chiba Y; Uematsu M; Hino-Fukuyo N; Tanaka S; Onuma A; Iinuma K; Tsuchiya S
J Neurol Sci; 2010 Oct; 297(1-2):19-28. PubMed ID: 20655547
[TBL] [Abstract][Full Text] [Related]
2. Platelet-derived growth factor and its receptors are related to the progression of human muscular dystrophy: an immunohistochemical study.
Zhao Y; Haginoya K; Sun G; Dai H; Onuma A; Iinuma K
J Pathol; 2003 Sep; 201(1):149-59. PubMed ID: 12950028
[TBL] [Abstract][Full Text] [Related]
3. Intramuscular renin-angiotensin system is activated in human muscular dystrophy.
Sun G; Haginoya K; Dai H; Chiba Y; Uematsu M; Hino-Fukuyo N; Onuma A; Iinuma K; Tsuchiya S
J Neurol Sci; 2009 May; 280(1-2):40-8. PubMed ID: 19232644
[TBL] [Abstract][Full Text] [Related]
4. Matrix-Metallo-Proteinases and their tissue inhibitors in radiation-induced lung injury.
Yang K; Palm J; König J; Seeland U; Rosenkranz S; Feiden W; Rübe C; Rübe CE
Int J Radiat Biol; 2007 Oct; 83(10):665-76. PubMed ID: 17729161
[TBL] [Abstract][Full Text] [Related]
5. Connective tissue growth factor is overexpressed in muscles of human muscular dystrophy.
Sun G; Haginoya K; Wu Y; Chiba Y; Nakanishi T; Onuma A; Sato Y; Takigawa M; Iinuma K; Tsuchiya S
J Neurol Sci; 2008 Apr; 267(1-2):48-56. PubMed ID: 17996907
[TBL] [Abstract][Full Text] [Related]
6. Expression profiling of muscles from Fukuyama-type congenital muscular dystrophy and laminin-alpha 2 deficient congenital muscular dystrophy; is congenital muscular dystrophy a primary fibrotic disease?
Taniguchi M; Kurahashi H; Noguchi S; Sese J; Okinaga T; Tsukahara T; Guicheney P; Ozono K; Nishino I; Morishita S; Toda T
Biochem Biophys Res Commun; 2006 Apr; 342(2):489-502. PubMed ID: 16487936
[TBL] [Abstract][Full Text] [Related]
7. Increased mRNA expression of tissue inhibitors of metalloproteinase-1 and -2 in Duchenne muscular dystrophy.
von Moers A; Zwirner A; Reinhold A; Brückmann O; van Landeghem F; Stoltenburg-Didinger G; Schuppan D; Herbst H; Schuelke M
Acta Neuropathol; 2005 Mar; 109(3):285-93. PubMed ID: 15616792
[TBL] [Abstract][Full Text] [Related]
8. Activation and localization of matrix metalloproteinase-2 and -9 in the skeletal muscle of the muscular dystrophy dog (CXMDJ).
Fukushima K; Nakamura A; Ueda H; Yuasa K; Yoshida K; Takeda S; Ikeda S
BMC Musculoskelet Disord; 2007 Jun; 8():54. PubMed ID: 17598883
[TBL] [Abstract][Full Text] [Related]
9. T and B lymphocyte depletion has a marked effect on the fibrosis of dystrophic skeletal muscles in the scid/mdx mouse.
Farini A; Meregalli M; Belicchi M; Battistelli M; Parolini D; D'Antona G; Gavina M; Ottoboni L; Constantin G; Bottinelli R; Torrente Y
J Pathol; 2007 Oct; 213(2):229-38. PubMed ID: 17668421
[TBL] [Abstract][Full Text] [Related]
10. Apoptotic myonuclei in human Duchenne muscular dystrophy.
Sandri M; Minetti C; Pedemonte M; Carraro U
Lab Invest; 1998 Aug; 78(8):1005-16. PubMed ID: 9714187
[TBL] [Abstract][Full Text] [Related]
11. Expression of transforming growth factor-beta 1 and its relation to endomysial fibrosis in progressive muscular dystrophy.
Yamazaki M; Minota S; Sakurai H; Miyazono K; Yamada A; Kanazawa I; Kawai M
Am J Pathol; 1994 Feb; 144(2):221-6. PubMed ID: 8311110
[TBL] [Abstract][Full Text] [Related]
12. Expression of tissue inhibitor of metalloproteinase-1 in progression muscular dystrophy.
Sun GL; Zhao S; Li P; Jiang HK
Neurosci Bull; 2006 Mar; 22(2):85-90. PubMed ID: 17687403
[TBL] [Abstract][Full Text] [Related]
13. Plasma transforming growth factor beta1, metalloproteinase-1 and tissue inhibitor of metalloproteinases-1 in acute viral hepatitis type B.
Flisiak R; Jaroszewicz J; Lapiński TW; Flisiak I; Rogalska M; Prokopowicz D
Regul Pept; 2005 Nov; 131(1-3):54-8. PubMed ID: 16081167
[TBL] [Abstract][Full Text] [Related]
14. [Expression of connective tissue growth factor in progressive muscular dystrophy].
Sun GL; Yao F; Jiang HK; Li P; Kazuhiro H
Zhonghua Er Ke Za Zhi; 2005 Oct; 43(10):753-7. PubMed ID: 16255854
[TBL] [Abstract][Full Text] [Related]
15. Dysbindin, syncoilin, and beta-synemin mRNA levels in dystrophic muscles.
Wakayama Y; Matsuzaki Y; Yamashita S; Inoue M; Jimi T; Hara H; Unaki A; Iijima S; Masaki H
Int J Neurosci; 2010 Feb; 120(2):144-9. PubMed ID: 20199207
[TBL] [Abstract][Full Text] [Related]
16. Specific changes in plasma concentrations of matrix metalloproteinase-2 and -9, TIMP-1 and TGF-beta1 in patients with distinct types of primary glomerulonephritis.
Bauvois B; Mothu N; Nguyen J; Nguyen-Khoa T; Nöel LH; Jungers P
Nephrol Dial Transplant; 2007 Apr; 22(4):1115-22. PubMed ID: 17205957
[TBL] [Abstract][Full Text] [Related]
17. Comparison of basic fibroblast growth factor in X-linked dystrophin-deficient myopathies of human, dog and mouse.
Anderson JE; Kakulas BA; Jacobsen PF; Johnsen RD; Kornegay JN; Grounds MD
Growth Factors; 1993; 9(2):107-21. PubMed ID: 8217214
[TBL] [Abstract][Full Text] [Related]
18. Utility of dystrophin and utrophin staining in childhood muscular dystrophy.
Sundaram C; Vydehi B; Meena K; Murthy J
Indian J Pathol Microbiol; 2004 Jul; 47(3):367-9. PubMed ID: 16295426
[TBL] [Abstract][Full Text] [Related]
19. Maturational defect of regenerating muscle fibers in cases with Duchenne and congenital muscular dystrophies.
Miike T
Muscle Nerve; 1983 Oct; 6(8):545-52. PubMed ID: 6196637
[TBL] [Abstract][Full Text] [Related]
20. Alterations in matrix metalloproteinase-9 levels and tissue inhibitor of matrix metalloproteinases-1 expression in a transforming growth factor-beta transgenic model of hydrocephalus.
Zechel J; Gohil H; Lust WD; Cohen A
J Neurosci Res; 2002 Sep; 69(5):662-8. PubMed ID: 12210832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
